Clinical Trials in Riverton, United States
Locations / Riverton, United States
Delta Trials records 133 clinical trials conducted in Riverton, United States, making it a notable site of clinical research activity. These trials across 476 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 10 trials in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Riverton has changed over time.
133
Total Trials
476
Conditions
10
Terminated since 2020
Browse by condition (476 total)
- Invasive breast carcinoma 4 trialsAll Invasive breast carcinoma trials
- Prostate adenocarcinoma 4 trialsAll Prostate adenocarcinoma trials
- Stage iiia breast cancer 4 trialsAll Stage iiia breast cancer trials
- Progesterone receptor negative 3 trialsAll Progesterone receptor negative trials
- All Stage iv squamous cell lung carcinoma ajcc v7 trials
- Stage iv lung cancer ajcc v8 3 trialsAll Stage iv lung cancer ajcc v8 trials
- Breast carcinoma 3 trialsAll Breast carcinoma trials
- Secondary hypogonadism 3 trialsAll Secondary hypogonadism trials
- Colorectal cancer 3 trialsAll Colorectal cancer trials
- All Clinical stage iv cutaneous melanoma ajcc v8 trials
- Stage iva prostate cancer ajcc v8 3 trialsAll Stage iva prostate cancer ajcc v8 trials
- Stage ii breast cancer 3 trialsAll Stage ii breast cancer trials
- All Clinical stage iii cutaneous melanoma ajcc v8 trials
- Stage iia breast cancer 3 trialsAll Stage iia breast cancer trials
- Hot flashes 3 trialsAll Hot flashes trials
- Unresectable melanoma 3 trialsAll Unresectable melanoma trials
- Her2/neu negative 3 trialsAll Her2/neu negative trials
- Stage iib breast cancer 3 trialsAll Stage iib breast cancer trials
- All Recurrent squamous cell lung carcinoma trials
- Estrogen receptor negative 3 trialsAll Estrogen receptor negative trials